Haemonetics (HAE) Accounts Payables (2010 - 2026)

Haemonetics' Accounts Payables history runs 17 years deep, the most recent figure standing at $51.1 million for Q1 2026.

• In Q1 2026, Accounts Payables fell 23.8% year-over-year to $51.1 million; the TTM figure through Mar 2026 stood at $51.1 million (down 23.8% YoY), while the FY2026 annual figure was $51.1 million, down 23.8% from the prior year.
• Accounts Payables was $51.1 million for Q1 2026 at Haemonetics, up from $48.7 million in the prior quarter.
• In the past five years, Accounts Payables ranged from a high of $80.2 million in Q3 2023 to a low of $46.0 million in Q2 2025.
• Historically, Accounts Payables has averaged $62.7 million across 5 years, with a median of $62.3 million in 2024.
• The sharpest annual moves came in 2022 and 2025: Accounts Payables soared 36.73% in 2022, then tumbled 40.19% in 2025.
• A 5-year view of Accounts Payables shows it stood at $63.8 million in 2022, then fell by 10.86% to $56.8 million in 2023, then increased by 10.81% to $63.0 million in 2024, then fell by 22.7% to $48.7 million in 2025, then increased by 4.85% to $51.1 million in 2026.
• The last three Accounts Payables figures came in at $51.1 million (Q1 2026), $48.7 million (Q4 2025), and $61.7 million (Q3 2025), per Business Quant data.